Anna Lidia Wojdała

Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay

Giovanni Bellomo, Andrea Toja, Federico Paolini Paoletti et al. · Alzheimer s & Dementia · 2024 · 84 citations · Full text

Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays

Giovanni Bellomo, Silvia Paciotti, Luis Concha‐Marambio et al. · Molecular Neurodegeneration · 2023 · 49 citations · Full text

Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias

Charlotte E. Teunissen, Leighann Kimble, Sherif Bayoumy et al. · Molecular & Cellular Proteomics · 2023 · 45 citations · Full text

Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: disease staging by NF-L, p-tau181, and GFAP

Anna Lidia Wojdała, Giovanni Bellomo, Lorenzo Gaetani et al. · Neurobiology of Disease · 2023 · 45 citations · Full text

Fully automated measurement of plasma Aβ42/40 and p‐tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts

Giovanni Bellomo, Sherif Bayoumy, Alfredo Megaro et al. · Alzheimer s & Dementia · 2024 · 36 citations · Full text